Cancer
Reports from Fred Hutchinson Cancer Research Center advance knowledge in cancer
Published in Blood Weekly, October 25th, 2007
Data detailed in 'Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning' have been presented. "'Allogeneic hematopoietic cell transplantation (HCT) after nonmyeloablative conditioning for hematologic malignancies depends on graft-versus-tumor effects for eradication of cancer. Here, we estimated relapse risks according to disease characteristics," researchers in the United States report.
"Between 1997 and 2006, 834 consecutive patients (median age, 55 years; range, 5-74 years) received related (n=498) or unrelated (n=336) HCT after 2 Gy total body irradiation alone (n=171) or combined...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-10-25)
More Articles from Blood Weekly
- Blood Cancer
Kiadis Pharma Announces ATIR Interim Clinical Results - Blood Cancer
The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals - Coagulation
Availability of Coagulation Testing Labs at Point of Sales Makes Technician Training Imperative - Cutaneous T-Cell Lymphoma
BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL) - Myeloma
Ten Years, Nearly a Half Million Calls - Peripheral Artery Disease
W. L. Gore & Associates Takes on Peripheral Vascular Disease at Vascular Interventional Advances (VIVA) Conference - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
